Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Craig Della Valle

Adult Reconstructive Orthopaedic Surgery Chicago, IL Medical Doctor

NPI 1780663690 CMS profile 80854

1611 W Harrison St, Ste 400, Chicago, IL 60612

Open in the dashboard

General payments

$2,351,669

258 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$222,606 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Craig Della Valle of Chicago, IL is reported in the CMS Open Payments database as having received $2,351,669 across 258 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $222,606 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $581,619 50
2024 General $407,053 43
2023 General $336,265 43
2022 General $286,944 31
2021 General $306,403 31
2020 General $232,166 32
2019 General $201,219 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Della Valle
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Craig Della Valle were reported at $581,619. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Craig Della Valle Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $201,219 $1,416 $292–$9,336 $163
2020 $232,166 $647 $141–$6,474 $114
2021 $306,403 $1,073 $211–$6,497 $132
2022 $286,944 $1,217 $236–$6,299 $149
2023 $336,265 $1,082 $246–$6,818 $160
2024 $407,053 $1,575 $323–$8,944 $164
2025 $581,619 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $1,158,781 120 payments
  2. DePuy Synthes Products, Inc. $585,705 53 payments
  3. Smith+Nephew, Inc. $533,247 48 payments
  4. Medwest Associates $36,142 2 payments
  5. Davol Inc. $12,661 5 payments
  6. Medical Device Business Services, Inc. $9,428 18 payments
  7. Signature Orthopaedics USA Corp $9,000 1 payment
  8. Cardinal Health 200, LLC $3,200 1 payment
  9. Ethicon US, LLC $2,925 1 payment
  10. Medacta USA, Inc. $192 2 payments
  11. Other $387 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,183,017 108 payments
  2. Consulting Fee $120,551 79 payments
  3. Debt forgiveness $18,071 1 payment
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,071 1 payment
  5. Honoraria $7,160 2 payments
  6. Food and Beverage $3,427 58 payments
  7. Travel and Lodging $1,373 9 payments
Products named General payments · program years 2019–2025
  1. PINNACLE $538,466 13 payments
  2. Persona Knees $358,916 8 payments
  3. Persona Knees $274,733 8 payments
  4. Persona Partial Knee System $226,646 5 payments
  5. LEGION $224,863 17 payments
  6. REDAPT $195,131 19 payments
  7. Persona Knees $160,444 4 payments
  8. LEGION Revision $115,285 8 payments
  9. LEGION TKS Recon Knees $51,632 4 payments
  10. LEGION TKS Recon Knees $48,307 4 payments
  11. Other $128,293 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

743

Median for Orthopaedic Surgery: 30

Drug cost

$5,357

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 115 $2,988
Meloxicam Generic 236 $631
Oxycodone Hcl Generic 67 $429
Gabapentin Generic 57 $427
Tramadol Hcl Generic 74 $358
Methylprednisolone Generic 47 $270
Amoxicillin Generic 125 $211
Clindamycin Hcl Generic 22 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

258 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record